1. Home
  2. HRTG vs DBVT Comparison

HRTG vs DBVT Comparison

Compare HRTG & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Insurance Holdings Inc.

HRTG

Heritage Insurance Holdings Inc.

HOLD

Current Price

$26.29

Market Cap

898.0M

Sector

Finance

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$18.15

Market Cap

769.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRTG
DBVT
Founded
2012
2002
Country
United States
France
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
898.0M
769.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
HRTG
DBVT
Price
$26.29
$18.15
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
$32.50
$31.75
AVG Volume (30 Days)
320.8K
611.1K
Earning Date
11-05-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
98.61
N/A
EPS
4.83
N/A
Revenue
$842,277,000.00
$5,502,000.00
Revenue This Year
$5.45
$1,768.71
Revenue Next Year
$7.27
$1,028.88
P/E Ratio
$5.43
N/A
Revenue Growth
6.12
N/A
52 Week Low
$9.89
$3.30
52 Week High
$31.98
$26.19

Technical Indicators

Market Signals
Indicator
HRTG
DBVT
Relative Strength Index (RSI) 37.92 51.96
Support Level $24.87 $16.49
Resistance Level $30.20 $19.62
Average True Range (ATR) 1.19 1.49
MACD -0.45 -0.46
Stochastic Oscillator 24.87 18.05

Price Performance

Historical Comparison
HRTG
DBVT

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: